AKN-028

Names

[ Name ]:
AKN-028

[Synonym ]:
akn-028
unii-y66is3cs0r

Biological Activity

[Description]:

AKN-028 is an orally active and potent FLT3 tyrosine kinase inhibitor (IC50 = 6 nM). AKN-028 causes dose-dependent inhibition of FLT3 autophosphorylation[1].

[Related Catalog]:

Research Areas >> Cancer

Signaling Pathways >> Apoptosis >> Caspase

Signaling Pathways >> Protein Tyrosine Kinase/RTK >> FLT3

[Target]

FLT3:6 nM (IC50)

CLK1:140 nM (IC50)

RPS6KA:220 nM (IC50)

VEGFR2:520 nM (IC50)

FGFR2:1200 nM (IC50)

Caspase 3

[In Vitro]

AKN-028 triggers apoptosis in MV4-11 by activation of caspase 3[1]. AKN-028 (10 μM) is cytotoxic to AML cell lines and induces apoptosis in the AML cell line MV4-11[1]. Cell Cytotoxicity Assay[1] Cell Line: AML cell line MV4-11. Concentration: 10 μM. Incubation Time: 24 h. Result: Was cytotoxic to primary AML cells, irrespective of FLT3 mutation status and quantitative FLT3 expression.

[In Vivo]

AKN-028 (15 mg/kg, Subcutaneously injection twice daily) exhibits anti-tumor activities for acute myeloid leukemia (AML) models[1]. Animal Model: Mice based AML and MV4-11 cells[1]. Dosage: 15 mg/kg. Administration: Subcutaneously injection twice daily. Result: Inhibited net growth of one of the primary AML samples (UPN26) in vivo and furthermore reduced the tumor mass of MV4-11 cell line.

[References]

[1]. A Eriksson, et al. The Novel Tyrosine Kinase Inhibitor AKN-028 Has Significant Antileukemic Activity in Cell Lines and Primary Cultures of Acute Myeloid Leukemia. Blood Cancer J. 2012 Aug 3;2(8):e81.

Chemical & Physical Properties

[ Molecular Formula ]:
C₁₇H₁₄N₆

[ Molecular Weight ]:
302.33300

[ Exact Mass ]:
302.12800

[ PSA ]:
95.74000

[ LogP ]:
3.34880

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.